Suven Pharmaceuticals Limited

NSE:SUVENPHAR.NS

1249.95 (INR) • At close October 17, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q3
Omzet 2,306.92,529.3042,198.1962,310.5373,475.5013,693.5623,537.7172,784.0183,387.9913,334.2893,915.8533,009.8832,638.0132,293.8232,749.3322,373.8812,382.3241,579.1691,787.0622,729.2761,973.9142,393.4041,269.152
Kosten van de omzet 1,4971,768.9421,051.419868.8191,335.4691,569.0011,570.0111,321.1761,394.0371,374.7421,656.9851,363.1441,155.9881,205.1261,017.2531,033.294946.362690.709708.9641,175.167662.927967.845544.009
Brutowinst 809.9760.3621,146.7771,441.7182,140.0322,124.5611,967.7061,462.8421,993.9541,959.5472,258.8681,646.7391,482.0251,088.6971,732.0791,340.5871,435.962888.461,078.0981,554.1091,310.9871,425.559725.143
Brutowinstmarge 0.3510.3010.5220.6240.6160.5750.5560.5250.5890.5880.5770.5470.5620.4750.630.5650.6030.5630.6030.5690.6640.5960.571
Onderzoek- en ontwikkelingskosten 22222.75922.82244.73920.8820.0922.69820.74622.32321.44221.88536.69423.52415.06326.58538.14230.78534.07926.91552.94327.37800
Algemene en administratieve kosten 0164.609000122.774000311.28100095.779000181.75200000
Verkoop- en marketingkosten 034.77500034.89300018.83300018.36900036.03700000
Verkoop-, algemene en administratieve kosten -77.4199.384144.185131.598287.44157.667181.306156.824265.856330.114250.087231.943100.818114.148213.471209.29174.442217.789154.208152.579170.487162.7770
Overige kosten 181.6170.537143.446198.417106.651113.995130.112109.2110.331-740.383646.85150.41157.829-98.90148.4293.56857.391-125.18448.87554.45224.446235.7411.857
Bedrijfskosten 144.6199.384622.85581.024595.787553.361623.148584.353600.178468.572503.723520.759425.864228.995438.192430.692385.782183.88337.637354.598341.38235.741285.134
Bedrijfsresultaat 665.3560.978667.3731,059.1111,544.2451,685.1951,474.67987.6891,393.7761,478.9911,755.1451,125.981,056.161859.7021,293.887909.8951,050.18704.58740.4611,199.511969.6071,189.818440.009
Bedrijfsresultaat ratio 0.2880.2220.3040.4580.4440.4560.4170.3550.4110.4440.4480.3740.40.3750.4710.3830.4410.4460.4140.4390.4910.4970.347
Totaal overige inkomsten en kosten netto 165.6147.541-12.69-5.02895.186-23.086-13.827-2.93495.815133.831639.434213.293273.064194.995181.11258.465128.505189.23336.37845.431159.917-42.555-8.601
Inkomen voor belasting 830.9708.519654.6831,054.0831,639.4311,662.1091,460.843984.7551,489.5911,612.8212,394.5791,339.2731,329.2251,054.6971,474.999968.361,178.685893.813776.8391,244.9421,129.5241,147.263431.408
Inkomen voor belasting ratio 0.360.280.2980.4560.4720.450.4130.3540.440.4840.6120.4450.5040.460.5360.4080.4950.5660.4350.4560.5720.4790.34
Belastingkosten 223.2174.787187.148258.442433.532422.396383.637264.192414.17696.142793.889369.425278.394223.538338.746227.57263.469151.99197.735314.894210.482399.03386.895
Nettowinst 607.7533.73467.535795.6411,2061,239.7131,077.206720.5631,075.421916.681,600.69969.8481,050.831831.1591,136.253740.79915.216741.823579.104930.048919.042748.23344.513
Nettowinstmarge 0.2630.2110.2130.3440.3470.3360.3040.2590.3170.2750.4090.3220.3980.3620.4130.3120.3840.470.3240.3410.4660.3130.271
WPA (Winst Per Aandeel) 2.392.11.843.134.744.874.232.834.223.66.293.814.133.264.462.913.62.912.273.653.612.941.35
Verwaterde WPA 2.392.11.843.134.744.874.232.834.223.66.293.814.133.264.462.913.62.912.273.653.612.941.35
EBITDA 799.3733.439794.8911,178.031,776.3081,804.7781,597.061,107.9941,619.153996.7792,507.0561,442.7941,440.4131,137.2751,589.8891,075.9911,281.3811,005.016908.8881,344.5271,222.6871,211.92497.267
EBITDA ratio 0.3460.290.3620.510.5110.4890.4510.3980.4780.2990.640.4790.5460.4960.5780.4530.5380.6360.5090.4930.6190.5060.392